Fibroblast growth factor 10 attenuates chronic obstructive pulmonary disease by protecting against glycocalyx impairment and endothelial apoptosis

por Jiang, Tian, Hu, Weiping, Zhang, Shaoyuan, Ren, Changhao, Lin, Siyun, Zhou, Zhenyu, Wu, Hao, Yin, Jun, Tan, Lijie
Publicado 2022

Neoadjuvant therapy with immunoagent (nivolumab) or placebo plus chemotherapy followed by surgery and adjuvant treatment in subjects with resectable esophageal squamous cell carcin...

por Yin, Jun, Lin, Siyun, Fang, Yong, Jiao, Heng, Chen, Zongwei, Tang, Han, Gu, Jianmin, Zhang, Shaoyuan, Sun, Linyi, Li, Yin, Han, Yongtao, Chen, Qixun, Chen, Haiquan, Li, Zhigang, Tan, Lijie
Publicado 2023

The Single Nucleotide Polymorphisms of AP1S1 are Associated with Risk of Esophageal Squamous Cell Carcinoma in Chinese Population

por Su, Feng, Fang, Yong, Yu, Jinjie, Jiang, Tian, Lin, Siyun, Zhang, Shaoyuan, Lv, Lu, Long, Tao, Pan, Huiwen, Qi, Junqing, Zhou, Qiang, Tang, Weifeng, Ding, Guowen, Wang, Liming, Tan, Lijie, Yin, Jun
Publicado 2022

Association of LAMA1 Single-Nucleotide Polymorphisms with Risk of Esophageal Squamous Cell Carcinoma among the Eastern Chinese Population

por Zhang, Shaoyuan, Fang, Yong, Su, Feng, Jiang, Tian, Yu, Jinjie, Lin, Siyun, Lv, Lu, Long, Tao, Pan, Huiwen, Qi, Junqing, Zhou, Qiang, Tang, Weifeng, Ding, Guowen, Wang, Liming, Tan, Lijie, Yin, Jun
Publicado 2023

Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial

por Yin, Jun, Yuan, Jingnan, Li, Yunjin, Fang, Yong, Wang, Ruoxi, Jiao, Heng, Tang, Han, Zhang, Shaoyuan, Lin, Siyun, Su, Feng, Gu, Jianmin, Jiang, Tian, Lin, Dong, Huang, Zhiliang, Du, Chaoxiang, Wu, Kui, Tan, Lijie, Zhou, Qing
Publicado 2023

Publisher Correction: Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial

por Yin, Jun, Yuan, Jingnan, Li, Yunjin, Fang, Yong, Wang, Ruoxi, Jiao, Heng, Tang, Han, Zhang, Shaoyuan, Lin, Siyun, Su, Feng, Gu, Jianmin, Jiang, Tian, Lin, Dong, Huang, Zhiliang, Du, Chaoxiang, Wu, Kui, Tan, Lijie, Zhou, Qing
Publicado 2023